Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
144
Filing Date
7/9/2024
Updated
7/10/24, 3:17 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities